MohsAIQ Registry
MohsAIQ is the national data registry of the American College of Mohs Surgery. MohsAIQ, pronounced "mosaic," stands for Mohs Advancing and Improving Quality. It supports the ACMS mission to promote and advance the highest standards of patient care with respect to Mohs surgery and dermatologic oncology. Ultimately, the registry will help the ACMS and its members demonstrate the value of Mohs surgery as patient-centered and highly effective. MohsAIQ will provide meaningful data about patients and physician performance in order to improve outcomes and maximize results under new payment models.
How to Enroll
Participation in the MohsAIQ registry is available to all ACMS members. Here's how to get started:
- Click the 'Download enrollment form' button below to open a single, fillable PDF form that includes legal documents. Once it opens in your web browser, download it to your computer and fill in the blank fields electronically. Return the completed form to the ACMS via email at registry@mohscollege.org.
- Participants will be sent training links for authorized staff and will be ready to start participating in MohsAIQ.
If you have any questions about the enrollment form or process, please contact Tammy O'Connell, CEHRS, at registry@mohscollege.org or call (414) 347-1103.
News and Resources
December 30, 2021
MohsAIQ Registry approved for 2022 MIPS Reporting
The ACMS is pleased to announce the MohsAIQ registry is approved for another year as a Qualified Clinical Data Registry by the Centers for Medicare and Medicaid Services for the 2022 reporting year under the Merit-based Incentive Payment System. MohsAIQ is the only reporting solution designed exclusively for Mohs surgeons to fulfill MIPS requirements. MohsAIQ was previously approved as a QCDR for 2019, 2020, 2021 calendar years and will report 2022 cases for participating MohsAIQ users by March 31, 2023 deadline.
Surgeons and institutions who participate in MohsAIQ will have the opportunity to maximize their MIPS performance and optimize reimbursement payments if they report through two different modalities; i.e. an electronic health record and a QCDR. ACMS members have ten (10) QCDR measures available to report to CMS through MohsAIQ and can attest to quality improvement activities and the registry is able to transmit your QRDA III files for Promoting Interoperability.
The CMS-approved MohsAIQ measures for Calendar Year 2022
- ACMS4 Surgical Site Infection Rate - Mohs Micrographic Surgery
- ACMS5 Documentation of High-Risk Squamous Cell Carcinoma Stage in Mohs Micrographic Surgery Record
- ACMS8 Limit quantity of opioids prescribed for pain management in patients following MMS
- ACMS9 Post-Operative Management of Field Cancerization after Mohs Micrographic Surgery
- ACMS10 Photographic and/or Anatomic Map Documentation to Prevent Wrong-Site Surgery
- ASPS22 Coordination of Care for Anticoagulated Patients Undergoing Reconstruction After Skin Cancer Resection
- ASPS24 Visits to the ER or Urgent Care Following Reconstruction After Skin Cancer Resection
- ASPS27 Avoidance of Post-operative Systemic Antibiotics for Office-based Setting for Closure and Reconstruction after Skin Resection Procedures
- ASPS28 Continuation of Anticoagulation Therapy in the Office-based Setting for Closure and Reconstruction after Skin Cancer Resection Procedures
- ASPS29 Avoidance of Opioid Prescriptions for Closure and Reconstruction After Skin Cancer Resection
Learn more about the Quality Payment Program here.
December 23, 2020
MohsAIQ Registry approved for 2021 MIPS Reporting
The ACMS is pleased to announce the MohsAIQ registry is approved for a third year as a Qualified Clinical Data Registry by the Centers for Medicare and Medicaid Services for the 2021 reporting year under the Merit-based Incentive Payment System. MohsAIQ is the only reporting solution designed exclusively for Mohs surgeons to fulfill MIPS requirements. MohsAIQ was previously approved as a QCDR for the 2019 and 2020 calendar years and will report 2020 cases for participating MohsAIQ users by March 31, 2021 deadline.
"As an academic facility, we are pleased to contribute to the MohsAIQ registry and its user-generated dataset which demonstrates the effectiveness of Mohs surgery fosters clinical research and improves patient outcomes. With the help of members of the Mohs College, we can continue to advance our specialty through this extraordinary pursuit."
Dr. David Chen, University of Vermont Medical Center, VT
Surgeons and institutions who participate in MohsAIQ will have the opportunity to maximize their MIPS performance in 2021 and optimize reimbursement payments in 2023 if they report through two different modalities; i.e. an electronic health record and a QCDR. ACMS members have ten (10) QCDR measures available to report to CMS through MohsAIQ and can attest to quality improvement activities and the registry is able to transmit your QRDA III files for Promoting Interoperability.
The CMS-approved MohsAIQ measures for Calendar Year 2021:
- ACMS2 Closing the Mohs Surgery Referral Loop: Transmission of Surgical Report
- ACMS3 Antibiotic Prophylaxis for High-Risk Cardiac / Orthopedic Cases prior to Mohs micrographic surgery-Prevention of Overuse
- ACMS4 Surgical Site Infection Rate - Mohs Micrographic Surgery
- ACMS5 Documentation of high-risk Squamous Cell Carcinoma Stage in Mohs
- ACMS8 Limit quantity of opioids prescribed for pain management in patients following MMS
- ASPS22 Coordination of care for anticoagulated patients undergoing reconstruction after skin cancer resection
- ASPS24 Visits to ER or urgent care following reconstruction after skin cancer resection
- ASPS27 Avoidance of post-operative systemic antibiotics for office-based Closures and reconstruction after skin cancer Procedures
- ASPS28 Continuation of Anticoagulation Therapy in the Office-based Setting for Closure and Reconstruction after Skin Cancer Resection Procedures
- ASPS29 Avoidance of Opioid Prescriptions for Closure and Reconstruction After Skin Cancer Resection
Learn more about the Quality Payment Program here.
August 10, 2020
Flexible Options for MIPS Reporting for 2020 Performance Year
Due to the Covid-19 pandemic, CMS has introduced flexible options for MIPS reporting for the 2020 Performance Year. As a reminder the 2020 MIPS Performance Year includes data from January 1, 2020 through December 31, 2020; the submission deadline is in March 2021; and the results of the 2020 Performance Year will be reflected in the 2022 payment adjustments. The updated MIPS reporting options offered by CMS due to the Covid-19 pandemic include the following:
- Submitting a hardship application to request reweighting and consideration of one or more MIPS measurement categories for 2020
- Submitting a hardship application to opt-out of all MIPS categories for 2020
We encourage you to carefully examine the information from CMS in this link as well as the information found here, which has detailed information related to the 2020 Quality Payment Program Exception Applications. We strongly urge you to consider the following points as you select the option that best suits your circumstances:
- Some individuals may qualify for automatic extreme and uncontrollable circumstances and, as such, do not need to submit an application
- If you submit data for a single performance category that has been reweighted, the data submission will override the performance category reweighting and you will receive a MIPS final score based on the data submitted
- An individual, group, or virtual group must be scored on at least two performance categories to earn a MIPS final score greater than the performance threshold
July 23, 2020
9-Minute Improvement Activities for MIPS Webinar
This 9-minute webinar will help you to understand the CMS Improvement Activities (IA) Program, a component of MIPS, and will guide you through the IA submission process in MohsAIQ. Prior to your MIPS submission, you will need to determine if you meet the criteria for hardship due to the COVID-19 pandemic or other circumstances. CMS has provided an Extreme and Uncontrollable Circumstances Exception for MIPS submission of the performance categories. Reviewing information at https://qpp.cms.gov/mips/exception-applications#extremeCircumstancesException-2020 will help you decide whether you meet any of these hardship circumstances. By filling out the application, if you qualify, you are choosing to forgo submission of one or more of the performance categories depending on how you have been affected by the COVID-19 pandemic. Your decision regarding this hardship exception is important to know prior to making your selections in MohsAIQ. This 2020 IA shortlist shows what we believe to be the 19 most relevant IA’s for Mohs Surgeons. It is suggested that IA’s be selected and initiated prior to October 2020 in order to have the required 90 days of participation.
March 31, 2020
MIPS & MohsAIQ, A Guide to MIPS Participation in Performance Year 2020
This four-page guide, prepared by the National Registry and Outcomes Committee, will assist you with your participation and understanding of the MIPS program for 2020.
January 8, 2020
MohsAIQ Registry approved for 2020 MIPS Reporting
The ACMS is pleased to announce the MohsAIQ registry has been approved for a second years as a Qualified Clinical Data Registry by the Centers for Medicare and Medicaid Services for the 2020 reporting year under the Merit-based Incentive Payment System. MohsAIQ is the only reporting solution designed exclusively for Mohs surgeons to fulfill MIPS requirements. MohsAIQ was previously approved as a QCDR for 2019 and will report 2019 cases for participating MohsAIQ users by March 31, 2020 deadline.
“My staff and I have found it easy to integrate the data input for MohsAIQ into our daily routine. MohsAIQ is essential to promote the quality, efficacy, benefits and usefulness of Mohs surgery. I encourage all members of the Mohs College to participate in this important endeavor for our specialty and its future.” – Dr. Jonathan Bingham, Great Falls Clinic, MT
Surgeons and institutions who participate in MohsAIQ will have the opportunity to maximize their MIPS performance in 2020 and optimize reimbursement payments in 2022 if they report through two different modalities; i.e. an electronic health record and a QCDR. ACMS members now have a total of ten (10) QCDR measures available to report to CMS through MohsAIQ and can attest to quality improvement activities.
The MohsAIQ measures are:
- ACMS1 Adherence to MMS Appropriate Use Criteria
- ACMS2 Closing the referral loop
- ACMS3 Antibiotic prophylaxis for high risk/orthopedic cases prior to MMS
- ACMS4 Surgical site infection rate
- ACMS5 Non-opioid pain management following MMS
- ACMS6 Management of perioperative anticoagulation with MMS
- ACMS7 Documentation of high-risk SCC tumor stage in MMS record
- ASPS148 Coordination of care for anticoagulated patients undergoing reconstruction
- ASPS150 Visits to ER or urgent care following reconstruction after skin cancer resection
- ASPS146 Avoidance of post-operative systemic antibiotics for office-based reconstruction after skin cancer
MohsAIQ Worksheet
This worksheet is meant to capture the current minimal ‘required information’ to be entered into the registry. Administrators and staff are encouraged to add additional information as well to MohsAIQ. The optional form is designed as a tool to relay information if the surgeon prefers to have staff enter cases. The surgeon may circle the correct responses and then a staff person can easily enter the information into MohsAIQ. If you haven’t started putting in cases this is the way to get started!
January 14, 2019
MohsAIQ Registry approved for 2019 MIPS Reporting
The ACMS is pleased to announce the MohsAIQ registry has been approved as a Qualified Clinical Data Registry by the Centers for Medicare and Medicaid Services for the 2019 reporting year under the Merit-based Incentive Payment System. MohsAIQ is the only reporting solution designed exclusively for Mohs surgeons to fulfill MIPS requirements.
The specialty-specific measures unique to MohsAIQ include:
- Adherence to Mohs Micrographic Surgery Appropriate Use Criteria
- Closing the Mohs Surgery Referral Loop: Transmission of Surgical Report
- Surgical Site Infection Rate – Mohs Micrographic Surgery
- Antibiotic Prophylaxis for High Risk Cardiac / Orthopedic Cases prior to Mohs micrographic surgery – Prevention of Overuse
Learn more about the Quality Payment Program here.
Powered by ArborMetrix
ArborMetrix, based in Ann Arbor, Michigan, is the vendor partner selected by the ACMS to develop and help administer MohsAIQ. ArborMetrix was founded by internationally-recognized surgeons and uses a technology platform purpose-built to support medical specialty society registries. It has provided custom registries for the American Society of Anesthesiologists, the Americas Hernia Society Quality Collaborative, the American Association of Endocrine Surgeons, the Pediatric Cardiac Critical Care Consortium, and other organizations.
MohsAIQ will leverage ArborMetrix’s flexible technology infrastructure, advanced analytics, and interactive dashboards to support quality improvement initiatives and clinical research leading to the identification of best practices. ArborMetrix aims for ACMS members and others who participate to be able to use MohsAIQ to satisfy quality reporting requirements from the Centers for Medicare and Medicaid Services’ (CMS) Quality Payment Program (QPP), under the Merit-based Incentive Payment System (MIPS) starting in 2019. ArborMetrix will be supporting the College’s self-nomination as a Qualified Clinical Data Registry for 2019.